Security key
92337R101
Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA)
CUSIP: 92337R101
Q1 2024 13F Holders as of 31 Mar 2024
- Type / Class
- Equity / Class A Common Stock, par value $0.001 per share
- Shares outstanding
- 72,325,000
- Total 13F shares
- 51,298,718
- Share change
- +9,949,719
- Total reported value
- $2,212,007,022
- Put/Call ratio
- 237%
- Price per share
- $43.12
- Number of holders
- 157
- Value change
- +$474,171,827
- Number of buys
- 119
- Number of sells
- 38
Report period
Q1 2024
Institutions
157
Top holders
10
VERA full security history
Newer quarter: Q2 2024
Previous quarter: Q4 2023
Vera Therapeutics, Inc. SEC filings
Vera Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92337R101
Recent filing periods:
Top shareholders of VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Commodore Capital LP |
13F
3/4/5
|
Company · 10%+ Owner |
7.5%
|
5,450,000
|
$83,821,000 | — | 31 Dec 2023 | |
| Kynam Capital Management, LP |
13F
|
Company |
5%
|
3,650,339
|
$56,142,214 | — | 31 Dec 2023 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
4.8%
|
3,467,156
|
$53,324,859 | — | 31 Dec 2023 | |
| FMR LLC |
13F
|
Company |
3.8%
|
2,774,372
|
$42,669,841 | — | 31 Dec 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.8%
|
2,754,894
|
$42,370,271 | — | 31 Dec 2023 | |
| Woodline Partners LP |
13F
|
Company |
3.5%
|
2,507,140
|
$38,559,813 | — | 31 Dec 2023 | |
| STATE STREET CORP |
13F
|
Company |
3%
|
2,181,058
|
$33,544,672 | — | 31 Dec 2023 | |
| Eversept Partners, LP |
13F
|
Company |
2.6%
|
1,914,830
|
$29,450,085 | — | 31 Dec 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.3%
|
1,633,608
|
$25,124,891 | — | 31 Dec 2023 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
2.1%
|
1,518,115
|
$23,348,609 | — | 31 Dec 2023 | |
| Carlyle Group Inc. |
3/4/5
13F
|
10%+ Owner · Company |
2%
from 13F
|
2,960,231
|
$53,284,158 | — | 17 Aug 2022 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.8%
|
1,328,540
|
$20,432,945 | — | 31 Dec 2023 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
1.5%
|
1,110,960
|
$17,086,565 | — | 31 Dec 2023 | |
| MORGAN STANLEY |
13F
|
Company |
1.4%
|
994,840
|
$15,300,638 | — | 31 Dec 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.4%
|
984,324
|
$15,138,903 | — | 31 Dec 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
782,716
|
$12,039,546 | — | 31 Dec 2023 | |
| Polar Capital Holdings Plc |
13F
|
Company |
1%
|
725,000
|
$11,150,500 | — | 31 Dec 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.9%
|
649,218
|
$9,984,973 | — | 31 Dec 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.88%
|
633,685
|
$9,746,075 | — | 31 Dec 2023 | |
| Altium Capital Management LLC |
13F
|
Company |
0.85%
|
615,000
|
$9,458,700 | — | 31 Dec 2023 | |
| AXA S.A. |
13F
|
Company |
0.53%
|
382,691
|
$5,885,788 | — | 31 Dec 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.44%
|
321,835
|
$4,949,823 | — | 31 Dec 2023 | |
| Alphabet Inc. |
13F
|
Company |
0.42%
|
301,580
|
$4,638,300 | — | 31 Dec 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.38%
|
277,956
|
$4,274,963 | — | 31 Dec 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.37%
|
270,362
|
$4,158,167 | — | 31 Dec 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.29%
|
210,039
|
$3,230,400 | — | 31 Dec 2023 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.28%
|
200,302
|
$3,080,645 | — | 31 Dec 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.27%
|
198,184
|
$3,048,071 | — | 31 Dec 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.24%
|
170,758
|
$2,626,258 | — | 31 Dec 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.18%
|
131,318
|
$2,019,671 | — | 31 Dec 2023 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.17%
|
124,151
|
$1,909,442 | — | 31 Dec 2023 | |
| UBS Group AG |
13F
|
Company |
0.16%
|
115,422
|
$1,775,190 | — | 31 Dec 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.16%
|
113,747
|
$1,749,429 | — | 31 Dec 2023 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.15%
|
106,972
|
$1,645,229 | — | 31 Dec 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.14%
|
101,292
|
$1,557,871 | — | 31 Dec 2023 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.11%
|
76,224
|
$1,172,000 | — | 31 Dec 2023 | |
| CITIGROUP INC |
13F
|
Company |
0.1%
|
70,305
|
$1,081,291 | — | 31 Dec 2023 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.09%
|
68,306
|
$1,050,546 | — | 31 Dec 2023 | |
| Crestline Management, L.P. |
13F
|
Company |
0.08%
|
60,069
|
$923,861 | — | 31 Dec 2023 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.07%
|
52,590
|
$809,000 | — | 31 Dec 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.07%
|
50,922
|
$783,181 | — | 31 Dec 2023 | |
| Swiss National Bank |
13F
|
Company |
0.07%
|
48,700
|
$749,006 | — | 31 Dec 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.07%
|
47,999
|
$738,213 | — | 31 Dec 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.05%
|
39,647
|
$609,771 | — | 31 Dec 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.05%
|
38,483
|
$591,869 | — | 31 Dec 2023 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.05%
|
32,680
|
$502,618 | — | 31 Dec 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.04%
|
31,345
|
$482,087 | — | 31 Dec 2023 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.04%
|
30,220
|
$464,784 | — | 31 Dec 2023 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.04%
|
28,005
|
$431,000 | — | 31 Dec 2023 | |
| PROFUND ADVISORS LLC |
13F
|
Company |
0.04%
|
27,769
|
$427,087 | — | 31 Dec 2023 |
Institutional Holders of Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA) as of Q1 2024
As of 31 Mar 2024,
Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA) was held by
157 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,298,718 shares.
The largest 10 holders included
Avoro Capital Advisors LLC, BlackRock Inc., COMMODORE CAPITAL LP, FMR LLC, Sofinnova Investments, Inc., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, VANGUARD GROUP INC, Eversept Partners, LP, and MORGAN STANLEY.
This page lists
157
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
93
Q1 2024 holders
157
Holder diff
64
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 Value $ | Q1 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.